Crossmark

Engineered nanoparticles for clinical assays

Crossref DOI link: https://doi.org/10.1038/s44222-024-00208-y

Published Online: 2024-07-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheong, Jiyong https://orcid.org/0000-0001-6652-9394
Jo, Ala https://orcid.org/0000-0003-4783-9957
Lee, Jangwon

Lee, Sujin https://orcid.org/0009-0006-5881-966X
Lee, Jung-uk https://orcid.org/0000-0001-5638-243X
Lee, Jae-Hyun https://orcid.org/0000-0002-9236-157X
Lee, Hakho https://orcid.org/0000-0002-0087-0909
Cheon, Jinwoo https://orcid.org/0000-0001-8948-5929
License Information

Text and Data Mining valid from 2024-07-08

Version of Record valid from 2024-07-08
More Information

Article History

Accepted: 4 June 2024

First Online: 8 July 2024

Competing interests

: The authors declare no competing interests.